Oberweis Asset Management’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $57.1M | Sell |
3,135,890
-290,370
| -8% | -$5.29M | 2.48% | 2 |
|
|
2025
Q1 | $68M | Buy |
3,426,260
+83,700
| +3% | +$1.66M | 3.39% | 1 |
|
|
2024
Q4 | $57.3M | Buy |
3,342,560
+435,480
| +15% | +$7.47M | 2.7% | 2 |
|
|
2024
Q3 | $58.1M | Buy |
2,907,080
+866,380
| +42% | +$17.3M | 2.98% | 1 |
|
|
2024
Q2 | $22.8M | Sell |
2,040,700
-750,000
| -27% | -$8.39M | 1.4% | 11 |
|
|
2024
Q1 | $18.4M | Buy |
2,790,700
+80,000
| +3% | +$528K | 1.33% | 7 |
|
|
2023
Q4 | $12.3M | Buy |
2,710,700
+632,300
| +30% | +$2.86M | 1.14% | 12 |
|
|
2023
Q3 | $7.44M | Buy |
2,078,400
+409,700
| +25% | +$1.47M | 0.79% | 24 |
|
|
2023
Q2 | $6.16M | Buy |
1,668,700
+499,200
| +43% | +$1.84M | 0.75% | 32 |
|
|
2023
Q1 | $3.87M | Buy |
1,169,500
+632,600
| +118% | +$2.09M | 0.6% | 37 |
|
|
2022
Q4 | $2.08M | Buy |
+536,900
| New | +$2.08M | 0.44% | 68 |
|